Traws Pharma, Inc.
TRAW · NASDAQ
Filings22
Total reported value$2.9M
| Manager | Shares | Value | Change |
|---|---|---|---|
| ORBIMED ADVISORS LLC | 605.5K | $1.3M | 0.0% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 330K | $726.0K | 0.0% |
| Vestal Point Capital, LP | 150K | $330.0K | +0.1% |
| VANGUARD GROUP INC | 87.3K | $192.0K | +45.9% |
| GEODE CAPITAL MANAGEMENT, LLC | 43.4K | $95.6K | +15.1% |
| Ikarian Capital, LLC | 28.5K | $62.7K | 0.0% |
| TWO SIGMA INVESTMENTS, LP | 22K | $48.4K | +21.3% |
| HRT FINANCIAL LP | 12.6K | $27.7K | +50.0% |
| XTX Topco Ltd | 10.7K | $23.6K | +50.0% |
| BlackRock, Inc. | 10K | $21.9K | 0.0% |
| CITIGROUP INC | 3.5K | $7.8K | +49.6% |
| MORGAN STANLEY | 719 | $1.6K | 0.0% |
| SBI Securities Co., Ltd. | 162 | $356.4 | 0.0% |
| BANK OF AMERICA CORP /DE/ | 102 | $224.4 | +7.3% |
| Vermillion & White Wealth Management Group, LLC | 96 | $211.2 | 0.0% |
| UBS Group AG | 6 | $13.2 | +100.2% |
| FMR LLC | 2 | $4.4 | 0.0% |
| ASSETMARK, INC | 2 | $4.4 | +50.0% |
| TWO SIGMA SECURITIES, LLC | 0 | $0.0 | +100.0% |
| RAYMOND JAMES FINANCIAL INC | 0 | $0.0 | +100.0% |
| Tower Research Capital LLC (TRC) | 0 | $0.0 | +100.0% |
| Alyeska Investment Group, L.P. | 0 | $0.0 | +100.0% |